prikaz prve stranice dokumenta Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling
Rad nije dostupan
diplomski rad
Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling

Vukušić, Kristina (2016)
Sveučilište u Rijeci
Odjel za biotehnologiju

Citirajte ovaj rad

Vukušić, K. (2016). Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling (Diplomski rad). Preuzeto s https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Diplomski rad, Sveučilište u Rijeci, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, Kristina. "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling." Diplomski rad, Sveučilište u Rijeci, 2016. https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić, K. (2016). 'Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling', Diplomski rad, Sveučilište u Rijeci, citirano: 12.07.2020., https://urn.nsk.hr/urn:nbn:hr:193:483208

Vukušić K. Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling [Diplomski rad]. Rijeka: Sveučilište u Rijeci; 2016 [pristupljeno 12.07.2020.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:193:483208

K. Vukušić, "Screening of FDA approved compounds with effect on modification of myofibroblast activation during cardiac remodeling", Diplomski rad, Sveučilište u Rijeci, Rijeka, 2016. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:193:483208

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.